# US 2001/0036651 A1 · Method of nucleic acid sequence selection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0036651 A1
- Document ID: US20010036651A1
- Status: Published application
- Kind: A1
- Application number: 09/018,989
- Filed: 1998-02-05
- Published: 2001-11-01
- Earliest claimed: 1993-08-10
- Inventors: WU-BO LI; CHRISTIAN GRUBER; JOEL A. JESSEE; JHY-JHU LIN
- Web page: https://patentgrep.com/patent/US20010036651A1

## CPC

- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12N 15/1013: {by using magnetic beads}
- C12N 15/1048: {SELEX}
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C12Q 1/6813: Hybridisation assays
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides a method for the rapid isolation and recovery of a desired target DNA or RNA molecules from a mixture or library containing such molecules. The method involves the use of biotinylated probes and enzymatic repair-cleavage to eliminate undesired library members from a sample.

## Claims

### Claim 1

A method for recovering a desired target nucleic acid molecule from a sample containing a mixture or library of single-stranded nucleic acid containing said molecule, wherein said method comprises the steps:
A. incubating said sample containing said nucleic acid mixture or library in the presence of a primer nucleic acid molecule complementary to a sequence of said desired target molecule; said incubation being under conditions sufficient to permit hybridization between said primer and said desired target molecule, and further sufficient to permit the template-dependent extension of said primer to thereby generate a double-stranded desired target molecule;
B. transforming single-stranded and double-stranded members of said mixture or library into a host cell, and
C. recovering said desired molecule from said cell.

### Claim 2 (depends on 1)

The method of claim 1, wherein prior to commencing step A, said method comprises the presteps:
(1) incubating an initial sample containing said nucleic acid mixture or library in the presence of a haptenylated nucleic acid probe molecule, said probe molecules having a sequence complimentary to a nucleotide sequence of said desired target molecule; said incubation being under conditions sufficient to permit said probe to hybridize to said desired target molecule and to thereby generate a hybridized molecule wherein said target molecule is bound to said probe;
(2) incubating said sample containing said nucleic acid mixture or library and biotinylated probe-target hybridized molecules of prestep (1) in the presence of a binding ligand of the hapten of said haptenylated probe, said binding ligand being conjugated to support; said incubation being sufficient to permit said probe molecules, and said probe-target hybridized molecule to become bound to said binding ligand of said support;
(3) recovering said probe-target hybridized molecules bound to said support from said nucleic acid mixture or library and any unbound biotinylated probe-target hybridized molecules of prestep (2); and
(4) incubating said recovered support containing said bound probe-target hybridized molecules under conditions sufficient to separate the strands of double-stranded molecules; said incubation thereby releasing said hybridized target molecule from said biotinylated probe, and generating a sample single-stranded desired target molecule for use in step (A).

### Claim 3 (depends on 1)

The method of claim 1, wherein said single-stranded nucleic acid molecule of said sample contains a nucleotide analog, and wherein after completing step A, but prior to commencing step B, said method additionally comprises the presteps:
(1′) incubating said generated double-stranded molecules in the presence of a nuclease capable of degrading nucleic acid containing nucleotide analog residues; and
(2′) incubating non-degraded nucleic acid with a primer under conditions sufficient to permit said primer to be extended in a template-dependent manner.

### Claim 4 (depends on 1)

The method of claim 1, wherein in step A, said template-dependent extension of said primer is conducted in the presence of a nuclease resistant nucleotide analog to thereby generate a double-stranded desired target molecule containing a residue of said nucleotide analog; and wherein prior to commencing said step B, said method additionally comprises the presteps:
(1″) incubating said generated double-stranded desired target molecule in the presence of a nuclease, wherein said nuclease is substantially unable to cleave a nucleic acid molecule containing said nucleotide analog residue, but is substantially capable of degrading both single-stranded nucleic acid molecules and double-stranded nucleic acid molecules that lack said nucleic acid analog residue; said incubation being under conditions sufficient to permit such degradation, and thereby substantially eliminating both single-stranded nucleic acid molecules and double-stranded nucleic acid molecules that lack said nucleic acid analog residue from said sample; and thereby forming a preparation having a substantial enrichment of said desired target molecule relative to said initial sample; and
(2″) recovering said desired molecule from said preparation of prestep (1″) to thereby form a library or mixture for said step B.

### Claim 5 (depends on 1)

The method of claim 1, wherein in step A said desired incubation is under conditions which minimize random hybridization.

### Claim 6 (depends on 2)

The method of claim 2, wherein in prestep (1) said desired incubation is under conditions which minimize random hybridization.

### Claim 7 (depends on 1)

The method of claim 1, wherein said desired target nucleic acid molecule is a DNA molecule.

### Claim 8 (depends on 7)

The method of claim 7, wherein said DNA molecule is a single-stranded DNA molecule.

### Claim 9 (depends on 1)

The method of claim 1, wherein said desired target nucleic acid molecule is an RNA molecule.

### Claim 10 (depends on 1)

The method of claim 1, wherein said desired target nucleic acid molecule is a single-stranded nucleic acid molecule.

### Claim 11 (depends on 1)

The method of claim 1, wherein said desired target molecule is a circular nucleic acid molecule.

### Claim 12 (depends on 11)

The method of claim 11, wherein said desired target molecule is a circular DNA molecule.

### Claim 13 (depends on 2)

The method of claim 2, wherein said hapten is biotin, and wherein said binding ligand of said hapten is avidin, streptavidin, or an antibody or antibody fragment that binds biotin.

### Claim 14 (depends on 13)

The method of claim 13, wherein said/binding ligand of biotin is avidin.

### Claim 15 (depends on 13)

The method of claim 13, wherein said binding ligand of biotin is streptavidin.

### Claim 16 (depends on 2)

The method of claim 2, wherein said support of said prestep (2) is a paramagnetic bead.

### Claim 17 (depends on 16)

The method of claim 16, wherein said haptenylated probe-target hybridized molecule bound to said paramagnetic bead is recovered by magnetic means.

### Claim 18 (depends on 2)

The method of claim 2, wherein in said primer molecule of step A is complementary to the same sequence of said desired target molecule as said probe molecule of substep (1).

### Claim 19 (depends on 2)

The method of claim 2, wherein in said primer molecule of step A is complementary to a sequence of said desired target molecule that differs from the sequence of said desired target molecule that is complementary to said probe molecule of substep (1).

### Claim 20 (depends on 3)

The method of claim 3, wherein said nucleic acid analog is deoxyuridine, and wherein said nuclease is UDG.

### Claim 21 (depends on 4)

The method of claim 4, wherein said nuclease does not cleave hemimethylated DNA.

### Claim 22 (depends on 21)

The method of claim 21, wherein said nucleic acid analog is 5-methylcytidine, and wherein said nuclease that does not cleave hemimethylated DNA is HhaI.

### Claim 23 (depends on 2)

The method of claim 2, wherein in prestep (1), said probe has a degenerate sequence.

### Claim 24 (depends on 4)

The method of claim 4, wherein in step A, said primer has a degenerate sequence.

### Claim 25 (depends on 1)

The method of claim 1, wherein said host cell is a bacterium.

### Claim 26 (depends on 1)

The method of claim 1, wherein said method additionally includes the step of amplifying said desired target molecule by an in vitro amplification reaction.

### Claim 27 (depends on 26)

The method of claim 26, wherein said in vitro amplification reaction is a polymerase chain reaction.
